Neurix is at the forefront of the stem cell research. We are constantly pursing new methods to improve the accessibility to the technology and improvement of drug development.
RESEARCH WITH NEURIX
Stem cell application technology is the key element of our research focus and the main source of our products. It benefits early compound discovery and drug development, through provision of valuable in vitro data, with the highest possible biological relevance in 100% human models. Our services portfolio is designed to answer the most pressing questions about efficiency and understanding of biological mechanisms, helping you make pre-clinical decisions with greater confidence.
Our experienced team of scientists and application experts work with you to plan, conduct, and interpret a tailored screening project, providing you results at a fraction of the cost of animal testing and human trials.
BlastomaBrain Glioblastoma invasion model
Glioblastoma invading neural organoids to asses drug efficiency on tumor growth, motility and metastasis.
VirionBrain Gene therapy testing
Virus invasion model
Assessing the efficiency for gene therapies and anti-viral drug compounds.
CellBrain Cell therapy testing
Testing the efficiency of cell therapy, cell survival and integration inside the neural tissue
Neurix offers drug discovery services and personalized development of in vitro disease models, assays, and in dept -omic analyses.
Phone: +41 22 379 46 43
Location: Avenue de la Roseraie 64
1205 Geneva, Switzerland